Inflammation and plaque vulnerability

Journal of Internal Medicine

Volumn 278, Issue 5, 2015, Pages 483-493

  Hansson, G K ^a   Libby, P ^b   Tabas, I ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

Atherosclerosis; Atherothrombosis; En dothelial erosion; Inflammation; Plaque rupture

Indexed keywords

CD40 LIGAND; COLLAGEN; FATTY ACID; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; LEUKOTRIENE; LIPOXIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PATTERN RECOGNITION RECEPTOR; PROTEIN; RESOLVIN; RIP1 PROTEIN; RIP3 PROTEIN; THROMBOPLASTIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE; MATRIX METALLOPROTEINASE;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTERY WALL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL DEATH; CHRONIC INFLAMMATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DENDRITIC CELL; EFFECTOR CELL; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; FIBRIN FORMATION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MAST CELL; NATURAL KILLER CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PHAGOCYTOSIS; PLAQUE RUPTURE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SMOOTH MUSCLE FIBER; TENSILE STRENGTH; TH1 CELL; TH17 CELL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; COMPLICATION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RUPTURE; THROMBOEMBOLISM; VASCULAR ENDOTHELIUM;

ANIMALS; CYSTEINE PROTEASES; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MATRIX METALLOPROTEINASES; PLAQUE, ATHEROSCLEROTIC; RUPTURE, SPONTANEOUS; THROMBOEMBOLISM;

EID: 84945496884     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12406     Document Type: Review

References (96)

1. Tabas I, Garcia-Cardena G, Owens GK. Recent insights into the cellular biology of atherosclerosis. J Cell Biol 2015; 209: 13-22.
2. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-25.
3. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of t cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986; 6: 131-8.
4. Hansson GK, Holm J, Jonasson L. Detection of activated t lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989; 135: 169-75.
5. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-12.
6. Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: From mice to humans. Immunity 2013; 38: 1092-104.
7. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res 2014; 114: 1867-79.
8. Duewell P, Kono H, Rayner KJ et al. Nlrp3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464: 1357-61.
9. Libby P, Warner S, Friedman GB. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 1988; 81: 487-98.
10. Loppnow H, Libby P. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest 1990; 85: 731-8.
11. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002; 105: 1158-61.
12. Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S, Witztum JL. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005; 25: 1213-9.
13. Miller YI, Choi SH, Wiesner P et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 2011; 108: 235-48.
14. Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM. Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation 2007; 116: 2043-52.
15. Saren P, Welgus HG, Kovanen PT. TNF-alpha and IL-1beta selectively induce expression of 92-kda gelatinase by human macrophages. J Immunol 1996; 157: 4159-65.
16. Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein e knockout mice. Arterioscler Thromb Vasc Biol 2004; 24: 2137-42.
17. Bjorkbacka H, Kunjathoor VV, Moore KJ et al. Reduced atherosclerosis in myd88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004; 10: 416-21.
18. Michelsen KS, Wong MH, Shah PK et al. Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein e. Proc Natl Acad Sci U S A 2004; 101: 10679-84.
19. Hermansson A, Johansson DK, Ketelhuth DF, Andersson J, Zhou X, Hansson GK. Immunotherapy with tolerogenic apolipoprotein b-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation 2011; 123: 1083-91.
20. Hermansson A, Ketelhuth DF, Strodthoff D et al. Inhibition of t cell response to native low-density lipoprotein reduces atherosclerosis. J Exp Med 2010; 207: 1081-93.
21. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A 1995; 92: 3893-7.
22. Frostegard J, Ulfgren AK, Nyberg P et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (th1) and macrophage-stimulating cytokines. Atherosclerosis 1999; 145: 33-43.
23. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991; 11: 1223-30.
24. Hansson GK, Hellstrand M, Rymo L, Rubbia L, Gabbiani G. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J Exp Med 1989; 170: 1595-608.
25. Choi JH, Cheong C, Dandamudi DB et al. Flt3 signaling-dependent dendritic cells protect against atherosclerosis. Immunity 2011; 35: 819-31.
26. Subramanian M, Thorp E, Hansson GK, Tabas I. Treg-mediated suppression of atherosclerosis requires myd88 signaling in dcs. J Clin Invest 2013; 123: 179-88.
27. Kaartinen M, Penttilä A, Kovanen PT. Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas. Arterioscler Thromb Vasc Biol 1994; 14: 966-72.
28. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137-40.
29. Farb A, Burke AP, Tang AL et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93: 1354-63.
30. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur Heart J 2013; 34: 719-28.
31. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 1989; 86: 2839-43.
32. Hamsten A. Hemostatic function and coronary artery disease. N Engl J Med 1995; 332: 677-8.
33. Virchow R. Der atheromatose prozess der arterien. Wien Med Wochenschr 1856; 6: 825-8.
34. Davies MJ, Thomas A. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death and crescendo angina. Br Heart J 1985; 53: 363-73.
35. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-71.
36. Constantinides P. The role of arterial wall injury in atherogenesis and arterial thrombogenesis. Zentralbl Allg Pathol 1989; 135: 517-30.
37. Stone GW, Maehara A, Lansky AJ et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011; 364: 226-35.
38. Cheng JM, Garcia-Garcia HM, de Boer SP et al. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the atheroremo-ivus study. Eur Heart J 2014; 35: 639-47.
39. Yonetsu T, Kakuta T, Lee T et al. In vivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomography. Eur Heart J 2011; 32: 1251-9.
40. Shah PK, Falk E, Badimon JJ et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995; 92: 1565-9.
41. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnarable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-503.
42. Newby AC. Metalloproteinases and vulnerable atherosclerotic plaques. Trends Cardiovasc Med 2007; 17: 253-8.
43. Michel JB. Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler Thromb Vasc Biol 2003; 23: 2146-54.
44. Liao X, Sluimer JC, Wang Y et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 2012; 15: 545-53.
45. Myoishi M, Hao H, Minamino T et al. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation 2007; 116: 1226-33.
46. Thorp E, Li G, Seimon TA, Kuriakose G, Ron D, Tabas I. Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of apoe-/- and ldlr-/- mice lacking chop. Cell Metab 2009; 9: 474-81.
47. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 1995; 147: 251-66.
48. Schrijvers DM, De Meyer GR, Kockx MM, Herman AG, Martinet W. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 25: 1256-61.
49. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol 2005; 25: 2255-64.
50. Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arterioscler Thromb Vasc Biol 2008; 28: 1421-8.
51. Ait-Oufella H, Pouresmail V, Simon T et al. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol 2008; 28: 1429-31.
52. Serhan CN, Fredman G, Yang R et al. Novel proresolving aspirin-triggered dha pathway. Chem Biol 2011; 18: 976-87.
53. Fredman G, Kamaly N, Spolitu S et al. Targeted nanoparticles containing the proresolving peptide ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci Transl Med 2015; 7: 275ra220.
54. Lin J, Li H, Yang M et al. A role of rip3-mediated macrophage necrosis in atherosclerosis development. Cell Rep 2013; 3: 200-10.
55. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
56. Henney AM, Wakeley PR, Davies MJ et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A 1991; 88: 8154-8.
57. Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res 2014; 114: 1852-66.
58. Kaartinen M, Penttila A, Kovanen PT. Mast cells in rupture-prone areas of human coronary atheromas produce and store tnf-alpha. Circulation 1996; 11: 2787-92.
59. Sukhova G, Shi G-P, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins s and k in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998; 102: 576-83.
60. Newby AC. Proteinases and plaque rupture: unblocking the road to translation. Curr Opin Lipidol 2014; 25: 358-66.
61. Ketelhuth DF, Back M. The role of matrix metalloproteinases in atherothrombosis. Curr Atheroscler Rep 2011; 13: 162-9.
62. Ovchinnikova O, Robertson AK, Wagsater D et al. T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of apoe(-/-) mice. Am J Pathol 2009; 174: 693-700.
63. Klingenberg R, Gerdes N, Badeau RM et al. Depletion of foxp3+ regulatory t cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest 2013; 123: 1323-34.
64. MacLeod AS, Hemmers S, Garijo O et al. Dendritic epidermal t cells regulate skin antimicrobial barrier function. J Clin Invest 2013; 123: 4364-74.
65. Gistera A, Robertson AK, Andersson J et al. Transforming growth factor-beta signaling in t cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci Transl Med 2013; 5: 196ra100.
66. Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of cd40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997; 96: 396-9.
67. Henn V, Slupsky JR, Gräfe M et al. Cd40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-4.
68. Mach F, Schonbeck U, Sukhova GK et al. Functional cd40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages - implications for cd40-cd40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A 1997; 94: 1931-6.
69. Lievens D, Zernecke A, Seijkens T et al. Platelet cd40 l mediates thrombotic and inflammatory processes in atherosclerosis. Blood 2010; 116: 4317-27.
70. Wolf D, Hohmann JD, Wiedemann A et al. Binding of cd40 l to mac-1's i-domain involves the eqlkksktl motif and mediates leukocyte recruitment and atherosclerosis-but does not affect immunity and thrombosis in mice. Circ Res 2011; 109: 1269-79.
71. Samuelsson B. Role of basic science in the development of new medicines: examples from the eicosanoid field. J Biol Chem 2012; 287: 10070-80.
72. Gabrielsen A, Qiu H, Back M et al. Thromboxane synthase expression and thromboxane a2 production in the atherosclerotic lesion. J Mol Med 2010; 88: 795-806.
73. MacKenzie KF, Clark K, Naqvi S et al. Pge(2) induces macrophage il-10 production and a regulatory-like phenotype via a protein kinase a-sik-crtc3 pathway. J Immunol 2013; 190: 565-77.
74. Back M, Bu DX, Branstrom R, Sheikine Y, Yan ZQ, Hansson GK. Leukotriene b4 signaling through nf-kappab-dependent blt1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc Natl Acad Sci U S A 2005; 102: 17501-6.
75. Qiu H, Gabrielsen A, Agardh HE et al. Expression of 5-lipoxygenase and leukotriene a4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci U S A 2006; 103: 8161-6.
76. Heller EA, Liu E, Tager AM et al. Inhibition of atherogenesis in blt1-deficient mice reveals a role for ltb4 and blt1 in smooth muscle cell recruitment. Circulation 2005; 112: 578-86.
77. Back M, Sultan A, Ovchinnikova O, Hansson GK. 5-lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation. Circ Res 2007; 100: 946-9.
78. Helgadottir A, Manolescu A, Thorleifsson G et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004; 36: 233-9.
79. Ingelsson E, Yin L, Back M. Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease. J Allergy Clin Immunol 2012; 129: 702-7 e702.
80. Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 2008; 22: 3595-606.
81. Petri MH, Laguna-Fernandez A, Gonzalez-Diez M, Paulsson-Berne G, Hansson GK, Back M. The role of the fpr2/alx receptor in atherosclerosis development and plaque stability. Cardiovasc Res 2015; 105: 65-74.
82. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. An assessment of the evidence and need for future research. Circulation 1997; 96: 4095-103.
83. Caligiuri G, Lévy B, Pernow J, Thorén P, Hansson GK. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A 1999; 96: 6920-4.
84. Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein e knockout mouse. Atherosclerosis 2001; 154: 399-406.
85. Schwartz SM, Galis ZS, Rosenfeld ME, Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007; 27: 705-13.
86. Matoba T, Sato K, Egashira K. Mouse models of plaque rupture. Curr Opin Lipidol 2013; 24: 419-25.
87. Katsuki S, Matoba T, Nakashiro S et al. Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes. Circulation 2014; 129: 896-906.
88. Sasaki T, Kuzuya M, Nakamura K et al. A simple method of plaque rupture induction in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 2006; 26: 1304-9.
89. Chen YC, Bui AV, Diesch J et al. A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microrna expression profiling. Circ Res 2013; 113: 252-65.
90. Van der Donckt C, Van Herck JL, Schrijvers DM et al. Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death. Eur Heart J 2015; 36: 1049-1058.
91. Williams H, Johnson JL, Carson KG, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein e knockout mice. Arterioscler Thromb Vasc Biol 2002; 22: 788-92.
92. Quillard T, Araujo HA, Franck G, Shvartz E, Sukhova G, Libby P. Tlr2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion. Eur Heart J 2015; 36: 1394-404.
93. Lundberg AM, Hansson GK. Innate immune signals in atherosclerosis. Clin Immunol 2010; 134: 5-24.
94. Carroll D, Ebrahim S, Tilling K, Macleod J, Smith GD. Admissions for myocardial infarction and world cup football: database survey. BMJ 2002; 325: 1439-42.
95. Leeka J, Schwartz BG, Kloner RA. Sporting events affect spectators' cardiovascular mortality: it is not just a game. Am J Med 2010; 123: 972-7.
96. Shiomi M, Ishida T, Kobayashi T et al. Vasospasm of atherosclerotic coronary arteries precipitates acute ischemic myocardial damage in myocardial infarction-prone strain of the Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 2013; 33: 2518-23.